Literature DB >> 10026399

Decreased nitric oxide production in patients with Behçet's disease.

A Orem1, B Vanizor, G Cimşit, E Kiran, O Değer, M Malkoç.   

Abstract

BACKGROUND: Behçet's disease is a chronic multisystemic disorder which is characterized by a relapsing systemic inflammatory process. One of the features of Behçet's disease is endothelial dysfunction resulting from many factors. OBJECTIVE AND METHODS: We conducted this study to show if there is any change of plasma nitrite and nitrate levels by using the enzymatic-spectrophotometric method as an indicator for nitric oxide (NO) production, considering the disease activity in patients with Behçet's disease. The study group consisted 21 patients and 20 healthy control subjects. We measured plasma nitrite and nitrate levels, and some acute-phase reactants including erythrocyte sedimentation rate, alpha-1-antitrypsin, alpha-2-macroglobulin and the neutrophil count. Blood samples were drawn before and after treatment of the patients.
RESULTS: Nitrite, nitrate and nitrite + nitrate levels in the active period of the disease were found to be decreased compared to the inactive period and the control group. No significant differences were observed in plasma nitrite and nitrate levels between the inactive period and the control group.
CONCLUSION: It was concluded that decreased NO production in patients with Behçet's disease may have critical biological activities relevant to pathologic events in the active period of the disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10026399     DOI: 10.1159/000018061

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  10 in total

1.  The association between vitamin D levels and oxidative stress markers in Egyptian Behcet's disease patients.

Authors:  Heba S Omar; Fatma Mohamed Taha; Suzanne Fouad; Fatma A Ibrahim; Aliaa El Gendy; Iman H Bassyouni; Reem El-Shazly
Journal:  Orphanet J Rare Dis       Date:  2022-07-15       Impact factor: 4.303

2.  Behçet's Disease as a Model of Venous Thrombosis.

Authors:  Micaela La Regina; Armen Yuri Gasparyan; Francesco Orlandini; Domenico Prisco
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

3.  Assessment of serum homocysteine, endothelin-1, and nitric oxide levels in behçet's disease.

Authors:  Abeer A Hodeib; Tarek A Elsharawy; Hisham A Fawzi
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

4.  Serum levels of natriuretic peptides in patients with Behcet's disease.

Authors:  Ramazan Yağci; Yüksel Totan; Ekin Ozlük; Hüseyin Ozyurt; Gülfer Akbay; Meral Ekşioğlu
Journal:  Clin Rheumatol       Date:  2008-04-15       Impact factor: 2.980

5.  Evaluation of nitric oxide synthase activity, nitric oxide, and homocysteine levels in patients with active Behcet's disease.

Authors:  Seyithan Taysi; Refik Ali Sari; Hakan Dursun; Adnan Yilmaz; Mustafa Keles; Kerim Cayir; Mehmet Akyuz; Abdullah Uyanik; Adem Guvenc
Journal:  Clin Rheumatol       Date:  2008-07-18       Impact factor: 2.980

6.  Angiotensin-converting enzyme gene and endothelial nitric oxide synthase gene polymorphisms in Behçet's disease with or without ocular involvement.

Authors:  Ahmet Dursun; Hatice Gul Durakbasi-Dursun; Recep Dursun; Savas Baris; Levent Akduman
Journal:  Inflamm Res       Date:  2009-03-03       Impact factor: 4.575

7.  Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease and rheumatic diseases with vasculitis.

Authors:  J U Kim; H K Chang; S S Lee; J W Kim; K T Kim; S W Lee; W T Chung
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

8.  Pathophysiology of the Behçet's Disease.

Authors:  Umit Türsen
Journal:  Patholog Res Int       Date:  2011-10-01

9.  A panel of oxidative stress assays does not provide supplementary diagnostic information in Behcet's disease patients.

Authors:  Yasemin D Akcay; Ferhan G Sagin; Kenan Aksu; Gokhan Keser; Emma Taylor; Iona Knight; Paul G Winyard; Eser Y Sozmen
Journal:  J Inflamm (Lond)       Date:  2012-04-03       Impact factor: 4.981

10.  Assessment of Plasma S-Nitrosothiol Concentration by Electron Paramagnetic Resonance Spectrometry and Plasma Nitrotyrosine Levels by ELISA in Behçet's Disease.

Authors:  Y D Akcay; I A Knight; E L Taylor; K Aksu; P G Winyard
Journal:  EJIFCC       Date:  2007-12-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.